| 词条 | Actarit |
| 释义 |
| Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 477241533 | IUPAC_name = (4-Acetamidophenyl)acetic acid | image = Actarit.png | alt = | tradename = | Drugs.com = {{Drugs.com|international|actarit}} | pregnancy_AU = | pregnancy_US = | pregnancy_category = | legal_AU = | legal_CA = | legal_UK = | legal_US = | legal_status = | routes_of_administration = | bioavailability = | protein_bound = | metabolism = | elimination_half-life = | excretion = | CAS_number_Ref = {{cascite|changed|??}} | CAS_number = 18699-02-0 | ATCvet = | ATC_prefix = None | ATC_suffix = | PubChem = 2018 | ChEMBL_Ref = {{ebicite|changed|EBI}} | ChEMBL = 1226203 | DrugBank_Ref = {{drugbankcite|correct|drugbank}} | DrugBank = | ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} | ChemSpiderID = 1941 | UNII_Ref = {{fdacite|correct|FDA}} | UNII = HW5B6351RZ | KEGG_Ref = {{keggcite|correct|kegg}} | KEGG = D01395 | chemical_formula = | C=10 | H=11 | N=1 | O=3 | molecular_weight = 193.20 g/mol | smiles = O=C(O)Cc1ccc(cc1)NC(=O)C | StdInChI_Ref = {{stdinchicite|correct|chemspider}} | StdInChI = 1S/C10H11NO3/c1-7(12)11-9-4-2-8(3-5-9)6-10(13)14/h2-5H,6H2,1H3,(H,11,12)(H,13,14) | StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} | StdInChIKey = MROJXXOCABQVEF-UHFFFAOYSA-N }}Actarit is a disease-modifying antirheumatic drug (DMARD) developed in Japan for use in rheumatoid arthritis.[1] References1. ^{{cite journal |pmid=9918236 |date=Jan 1999 |last1=Takeba |first1=Y |last2=Suzuki |last3=Wakisaka |last4=Nagafuchi |last5=Mihara |last6=Kaneko |last7=Asai |last8=Sakane |title=Effects of actarit on synovial cell functions in patients with rheumatoid arthritis |volume=26 |issue=1 |pages=25–33 |issn=0315-162X |journal=The Journal of Rheumatology |first2=N |first3=S |first4=H |first5=S |first6=A |first7=T |first8=T}} {{antineoplastic-drug-stub}} 3 : Anti-inflammatory agents|Anilides|Acetamides |
| 随便看 |
|
开放百科全书收录14589846条英语、德语、日语等多语种百科知识，基本涵盖了大多数领域的百科知识，是一部内容自由、开放的电子版国际百科全书。